CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-09 | Patel Sanj K Chairman & CEO | Purchase · Series C Preferred Shares | +63,922 | $15.64 | $1000K | 63,922 |
| 2018-02-09 | Beetham Thomas W. Chief Legal Officer | Purchase · Series C Preferred Shares | +6,392 | $15.64 | $100K | 6,392 |
| 2018-02-09 | BOESS CARSTEN 10% owner | Purchase · Series C Preferred Shares | +6,392 | $15.64 | $100K | 6,392 |
| 2018-02-09 | Mahoney Stephen F. President & COO | Purchase · Series C Preferred Shares | +6,392 | $15.64 | $100K | 6,392 |
| 2018-02-09 | Heberlig Chris Exec VP & CFO | Purchase · Series C Preferred Shares | +6,392 | $15.64 | $100K | 6,392 |
Page 81 of 81 · 1,605 trades